BETTERLIFE PHARMA INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value

BETTERLIFE PHARMA INC. (BETRF) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $0.38 per share as of 2017-10-31, per its 10-Q filed 2017-12-15.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2017-12-15

2017-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.38.
2017-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.38.
2017-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.38.
2017-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.38.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
2017-10-31	$0.38 10-Q · filed 2017-12-15
2017-07-31	$0.38 10-Q · filed 2017-09-15
2017-04-30	$0.38 10-Q · filed 2017-06-13
2017-01-31	$0.38 10-Q · filed 2017-12-15
2016-10-31	$0.48 10-Q · filed 2016-12-12
2016-07-31	$0.48 10-Q · filed 2016-09-12
2016-04-30	$0.43 10-Q · filed 2016-06-14
2016-01-31	$0.10 10-Q · filed 2016-12-12
2015-01-31	$0.05 10-Q · filed 2016-12-12
2014-01-31	$0.05 10-K/A · filed 2016-06-07